Galderma Acquires ALASTIN Skincare
January 5, 2022
Galderma has completed the acquisition of ALASTIN Skincare, Inc., receiving U.S. antitrust clearance and closing the deal announced November 29, 2021. The purchase adds ALASTIN's physician-dispensed aesthetic skincare portfolio, including its patented TriHex Technology, to Galderma's integrated dermatology platform to expand product capabilities and better serve aesthetic professionals and consumers.
- Buyers
- Galderma
- Targets
- ALASTIN Skincare, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Taro Acquires Alchemee (Proactiv) from Galderma
February 28, 2022
Consumer Products
Taro Pharmaceutical Industries Ltd. has completed its acquisition of Alchemee (formerly The Proactiv Company) and the Proactiv brand from Galderma. The deal expands Taro's over-the-counter dermatology portfolio and adds Alchemee's omni-channel marketing capabilities to support continued growth of the Proactiv brand.
-
L'Oréal Acquires Skinbetter Science
September 23, 2022
Consumer Products
L'Oréal has signed an agreement to acquire Skinbetter Science, a physician-dispensed U.S. skincare brand known for dermatology-backed, clinical formulations. Skinbetter Science—headquartered in Phoenix, Arizona and reporting nearly $95 million in trailing‑12‑month sales to August 31, 2022—will be integrated into L'Oréal USA's Active Cosmetics Division while its leadership team remains in place.
-
NovaBay Pharmaceuticals Acquires DERMAdoctor
September 28, 2021
Consumer Products
NovaBay Pharmaceuticals, Inc. has entered into a definitive agreement to acquire DERMAdoctor, LLC for $15.0 million ( $12.0 million cash at closing plus up to $3.0 million in earnouts). The deal brings DERMAdoctor's ~30-product skincare portfolio and its 13-person team (co-founders Audrey and Jeff Kunin to remain) into NovaBay's commercial platform to expand its presence in the U.S. beauty market and capture revenue and operating synergies.
-
DermBiont Acquires SeylanMED to Expand Dermatology Pipeline
October 21, 2020
Biotechnology
DermBiont, a Boston-based clinical-stage precision dermatology company, has acquired SeylanMED, adding a targeted topical AKT inhibitor gel candidate for seborrheic keratosis to its pipeline. The acquisition expands DermBiont's therapeutic modalities and accelerates its objective to develop targeted topical treatments and live bacterial therapeutics for skin diseases.
-
Clinical Skin Acquires Glytone from Pierre Fabre Laboratories
March 4, 2024
Consumer Products
Clinical Skin has acquired cosmeceutical skincare brand Glytone from Pierre Fabre Laboratories in a strategic move to expand its science-backed product portfolio. Glytone, known for dermatologist-trusted formulations targeting aging, hyperpigmentation and acne, will be integrated into Clinical Skin's offering to further scale its presence in the skincare market.
-
Eurofins Scientific Acquires bioskin GmbH
August 4, 2021
Healthcare Services
Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.